F270-0031 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide

F270-0031 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide
F270-0031 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F270-0031
2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F270-0031

Molecular Formula

C24H23ClN4O5 (C24 H23 ClN4 O5)

Compound Name

2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide

IUPAC name

2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]-N-[2-(34-dimethoxyphenyl)ethyl]acetamide

SMILES

Cc(onc12)c2C(c(cc2)ccc2Cl)=NN(CC(NCCc(cc2)cc(OC)c2OC)=O)C1=O

InChI

InChI=1S/C24H23ClN4O5/c1-14-21-22(16-5-7-17(25)8-6-16)27-29(24(31)23(21)28-34-14)13-20(30)26-11-10-15-4-9-18(32-2)19(12-15)33-3/h4-9,12H,10-11,13H2,1-3H3,(H,26,30)

InChI Key

PAFHVMAALCWVAN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.92

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.172

Distribution Coefficient, logD

2.172

Water Solubility, LogSw

-3.73

Polar Surface Area

89.092

Acid Dissociation Constant (pKa)

15.06

Base Dissociation Constant (pKb)

1.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F270-0031 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Targeted Diversity Library (40567 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F270-0031 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F270-0031?
Check Price and Availability of F270-0031, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F270-0031 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F270-0031
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F270-0031
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F270-0031 available by request